MarketPeel
Insider Trading Intelligence
Pricing
…
SB

Scott Bizily

FDMT
CHIEF LEGAL OFFICER · 4D MOLECULAR THERAPEUTICS, INC. · CIK 0001920738
FILING MIX · LIFETIME37%/63%
BUYS
44
SELLS
74
TOTAL VALUE
$2.42M
COMPANIES
1
ACTIVE SINCE
Jun 2022
HOLDINGS NOW
9,431
AVG SELL PX
$21.36
TRADE KIND
SHOWING 118 / 118
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
33 backtested trades · 8 horizons · 16 pending
Forward-return performance of every backtestable P/S trade by Scott Bizily, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d33+48.48%-3.30%-0.40%-2.90%-1.01%-1.18
14d33+57.58%-5.85%-0.88%-4.97%-4.06%-2.10
30d33+72.73%-7.81%-0.57%-7.24%+1.97%-2.30
60d33+72.73%-11.77%+1.99%-13.76%-6.50%-4.03
90d33+90.91%-23.93%+2.92%-26.85%-17.71%-7.85
180d33+93.94%-39.26%+6.98%-46.24%-47.83%-8.83
1y33(6 pending)+92.59%-60.96%+15.66%-76.62%-94.84%—
2y33(10 pending)+100.00%-66.20%+42.62%-108.82%-107.37%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
FDMT · 9,431 shares · as of Jun 30, 2026
054,250108,500162,750217,0002023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 44 buys / 74 sellsCOVERAGE · 17 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
814$4.14$3.4K9,431Jun 30, 2026Jul 2, 2026 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
814——62,971Jun 30, 2026Jul 2, 2026 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
5,752$6.49$37.3K15,183Jun 30, 2026Jul 2, 2026 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
5,752——3,543Jun 30, 2026Jul 2, 2026 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
6,566$14.00$91.9K8,617Jun 30, 2026Jul 2, 2026 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
9,810$4.14$40.6K18,427Jun 23, 2026Jun 25, 2026 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
9,810——63,785Jun 23, 2026Jun 25, 2026 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
9,810$12.00$117.7K8,617Jun 23, 2026Jun 25, 2026 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
217,000——217,000Mar 25, 2026Mar 27, 2026 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,635$4.14$6.8K5,229Dec 16, 2025Dec 19, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,635——73,595Dec 16, 2025Dec 19, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,635$10.90$17.8K3,594Dec 16, 2025Dec 19, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,635——75,230Nov 17, 2025Nov 19, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,635$4.14$6.8K5,229Nov 17, 2025Nov 19, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,635$10.59$17.3K3,594Nov 17, 2025Nov 19, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,084——9,295Oct 24, 2025Oct 27, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,678$12.00$32.1K3,594Oct 24, 2025Oct 27, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,084$6.49$7.0K6,272Oct 24, 2025Oct 27, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,635——76,865Oct 16, 2025Oct 20, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,635$4.14$6.8K6,823Oct 16, 2025Oct 20, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,635$10.17$16.6K5,188Oct 16, 2025Oct 20, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,408$10.00$24.1K5,188Oct 9, 2025Oct 14, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,407$8.00$19.3K7,596Sep 23, 2025Sep 26, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
78,500——78,500Mar 6, 2025Mar 10, 2025 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
500$16.33$8.2K6,781Sep 16, 2024Sep 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
500——10,379Sep 16, 2024Sep 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
500$6.49$3.2K7,281Sep 16, 2024Sep 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
500$15.00$7.5K6,781Aug 19, 2024Aug 21, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
500$6.49$3.2K7,281Aug 19, 2024Aug 21, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
500——10,879Aug 19, 2024Aug 21, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
500$6.49$3.2K7,281Jul 16, 2024Jul 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
500——11,379Jul 16, 2024Jul 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,250$8.04$10.1K8,531Jul 16, 2024Jul 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,750$27.11$47.4K6,781Jul 16, 2024Jul 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,250——32,502Jul 16, 2024Jul 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,996$15.78$31.5K8,777Jul 11, 2024Jul 15, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,996——23,004Jul 11, 2024Jul 15, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,996$25.00$49.9K6,781Jul 11, 2024Jul 15, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
2,916——33,752Jul 1, 2024Jul 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,248$21.36$90.8K1,737Jul 1, 2024Jul 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,332——11,879Jul 1, 2024Jul 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
2,916$8.04$23.4K5,985Jul 1, 2024Jul 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,332$6.49$8.6K3,069Jul 1, 2024Jul 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,250$8.04$10.1K3,487Jun 17, 2024Jun 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
500——13,211Jun 17, 2024Jun 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,750$23.71$41.5K1,737Jun 17, 2024Jun 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,250——36,668Jun 17, 2024Jun 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
500$6.49$3.2K2,237Jun 17, 2024Jun 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
500——13,711May 16, 2024May 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,250——37,918May 16, 2024May 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,283$25.34$32.5K2,204May 16, 2024May 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
500$6.49$3.2K2,237May 16, 2024May 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,250$8.04$10.1K3,487May 16, 2024May 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
467$25.75$12.0K1,737May 16, 2024May 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,250$8.04$10.1K3,487Apr 16, 2024Apr 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,750$25.74$45.0K1,737Apr 16, 2024Apr 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,250——39,168Apr 16, 2024Apr 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
500——14,211Apr 16, 2024Apr 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
500$6.49$3.2K2,237Apr 16, 2024Apr 18, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,909——46,182Apr 1, 2024Apr 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
8,153$31.78$259.1K1,737Apr 1, 2024Apr 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,996——21,008Apr 1, 2024Apr 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,909$20.24$38.6K9,890Apr 1, 2024Apr 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,996$15.78$31.5K7,981Apr 1, 2024Apr 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
2,916$8.04$23.4K5,985Apr 1, 2024Apr 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,332——14,711Apr 1, 2024Apr 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,332$6.49$8.6K3,069Apr 1, 2024Apr 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
2,916——40,418Apr 1, 2024Apr 3, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
4,342——55,658Mar 27, 2024Mar 29, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
4,342$25.98$112.8K6,079Mar 27, 2024Mar 29, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,491——54,167Mar 27, 2024Mar 29, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,491$25.98$38.7K7,570Mar 27, 2024Mar 29, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
5,833$35.04$204.4K1,737Mar 27, 2024Mar 29, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,250$8.04$10.1K3,487Mar 18, 2024Mar 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
500$6.49$3.2K2,237Mar 18, 2024Mar 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,250——43,334Mar 18, 2024Mar 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
500——16,043Mar 18, 2024Mar 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,750$31.27$54.7K1,737Mar 18, 2024Mar 20, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,909$20.24$38.6K3,646Feb 27, 2024Feb 29, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,909$30.00$57.3K1,737Feb 27, 2024Feb 29, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,909——48,091Feb 27, 2024Feb 29, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,750$27.67$48.4K1,737Feb 16, 2024Feb 21, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
500$6.49$3.2K2,237Feb 16, 2024Feb 21, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,250——44,584Feb 16, 2024Feb 21, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,250$8.04$10.1K3,487Feb 16, 2024Feb 21, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
500——16,543Feb 16, 2024Feb 21, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,332$6.49$8.6K3,069Feb 8, 2024Feb 12, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
1,996$15.78$31.5K3,733Feb 8, 2024Feb 12, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal Officer
2,916$8.04$23.4K4,653Feb 8, 2024Feb 12, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
2,916$27.50$80.2K1,737Feb 8, 2024Feb 12, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,996——23,004Feb 8, 2024Feb 12, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
2,916——45,834Feb 8, 2024Feb 12, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,332$27.50$36.6K1,737Feb 8, 2024Feb 12, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,996$27.50$54.9K1,737Feb 8, 2024Feb 12, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal Officer
1,332——17,043Feb 8, 2024Feb 12, 2024 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
130,000——130,000Dec 11, 2023Dec 13, 2023 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal and HR Officer
3,750$8.04$30.1K5,859Apr 21, 2023Apr 25, 2023 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
3,750——52,500Apr 21, 2023Apr 25, 2023 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,750$20.00$75.0K2,109Apr 21, 2023Apr 25, 2023 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
1,875——20,250Mar 1, 2023Mar 3, 2023 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal and HR Officer
1,875$6.49$12.2K4,357Mar 1, 2023Mar 3, 2023 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
2,248$19.30$43.4K2,109Mar 1, 2023Mar 3, 2023 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
50,000——50,000Feb 10, 2023Feb 14, 2023 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal and HR Officer
3,750$8.04$30.1K6,607Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
400$21.52$8.6K4,332Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
975$22.71$22.1K3,357Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
400$23.25$9.3K2,957Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
1,875——22,125Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
1,000$21.78$21.8K5,607Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
200$23.44$4.7K2,957Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
100$24.49$2.4K2,857Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
375$24.35$9.1K2,482Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
100$24.49$2.4K2,857Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
2,450$22.93$56.2K3,157Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASE
Chief Legal and HR Officer
1,875$6.49$12.2K4,732Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
SALE
Chief Legal and HR Officer
3,750——56,250Dec 1, 2022Dec 5, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
60,000——60,000Sep 1, 2022Sep 2, 2022 ↗View →
FDMT
4D MOLECULAR THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
24,000——24,000Jun 18, 2022Jun 21, 2022 ↗View →
Other insiders · FDMT
Loading peer insiders…
About this filer
CIK 0001920738
ROLE
Chief Legal Officer
PRIMARY
FDMT
COMPANIES
1
ACTIVE SINCE
Jun 2022
MARKETPEEL · /INSIDER/0001920738DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback